当前位置: X-MOL 学术Biomol. Biomed. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature.
Biomolecules and Biomedicine ( IF 3.1 ) Pub Date : 2022-04-01 , DOI: 10.17305/bjbms.2021.6419
Zhe-Sheng Chen 1 , Dong-Hua Yang 2
Affiliation  



中文翻译:

单核苷酸多态性特征指导下早期结外自然杀伤/T细胞淋巴瘤患者最佳治疗方式的选择

更新日期:2021-08-24
down
wechat
bug